Borden Cottage, a luxury residential drug, alcohol, and co-occurring behavioral health treatment program in Camden, ME, has transitioned to an independent ownership and operational structure. Since its establishment in 2015, Borden Cottage has provided treatment for addiction and co-occurring conditions. Under the clinical oversight of Harvard Medical School-affiliated McLean Hospital, Borden Cottage established a strong foundation and reputation in the industry.
Under its new leadership, Borden Cottage will continue to offer care and a comprehensive range of evidence-based therapies. Tom Rodman, CEO of the company that owns the property, now serves as Borden Cottage’s CEO.
Borden Cottage is a 12-bed residential drug, alcohol, and co-occurring mental health treatment program, originally founded in 2015 under the name McLean Borden Cottage. Read more.
